Quality of Life Research

, Volume 23, Issue 1, pp 75–88 | Cite as

Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study

  • D. MarreroEmail author
  • Q. Pan
  • E. Barrett-Connor
  • M. de Groot
  • P. Zhang
  • C. Percy
  • H. Florez
  • R. Ackermann
  • M. Montez
  • R. R. Rubin
  • the DPPOS Research Group



The purpose of this study is to assess if diagnosis of type 2 diabetes affected health-related quality of life (HRQoL) among participants in the Diabetes Prevention Program/Diabetes Prevention Program Outcome Study and changes with treatment or diabetes duration.


3,210 participants with pre-diabetes were randomized to metformin (MET), intensive lifestyle intervention (ILS), or placebo (PLB). HRQoL was assessed using the SF-36 including: (1) 8 SF-36 subscales; (2) the physical component (PCS) and mental component summary (MCS) scores; and (3) the SF-6D. The sample was categorized by diabetes free versus diagnosed. For diagnosed subgroup, mean scores in the diabetes-free period, at 6 months, 2, 4 and 6 years post-diagnosis, were compared.


PCS and SF-6D scores declined in all participants in all treatment arms (P < .001). MCS scores did not change significantly in any treatment arm regardless of diagnosis. ILS participants reported a greater decrease in PCS scores at 6 months post-diagnosis (P < .001) and a more rapid decline immediately post-diagnosis in SF-6D scores (P = .003) than the MET or PLB arms. ILS participants reported a significant decrease in the social functioning subscale at 6 months (P < .001) and two years (P < .001) post-diagnosis.


Participants reported a decline in measures of overall health state (SF-6D) and overall physical HRQoL, whether or not they were diagnosed with diabetes during the study. There was no change in overall mental HRQoL. Participants in the ILS arm with diabetes reported a more significant decline in some HRQoL measures than those in the MET and PLB arms that developed diabetes.


Diagnosis of diabetes  Health-related quality of life  Pre-diabetes  Type 2 diabetes mellitus  Prevention 



The Research Group gratefully acknowledges the commitment and dedication of the participants of the DPP and DPPOS. During the DPPOS, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study, and collection, management, analysis, and interpretation of the data (U01 DK048489). The Southwestern American Indian Centers were supported directly by the NIDDK, including its Intramural Research Program, and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centers. Funding was also provided by the National Institute of Child Health and Human Development, the National Institute on Aging, the National Eye Institute, the National Heart Lung and Blood Institute, the Office of Research on Women’s Health, the National Center for Minority Health and Human Disease, the Centers for Disease Control and Prevention, and the American Diabetes Association. Bristol-Myers Squibb and Parke-Davis provided additional funding and material support during the DPP, Lipha (Merck-Sante) provided medication, and LifeScan Inc. donated materials during the DPP and DPPOS. We thank the thousands of volunteers in this program for their devotion to the goal of diabetes prevention. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center. The opinions expressed are those of the investigators and do not necessarily reflect the views of the funding agencies.


  1. 1.
    Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.PubMedCrossRefGoogle Scholar
  2. 2.
    Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002). Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ, 324(1417), 1.Google Scholar
  3. 3.
    Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A., & Crofts, N. (1999). The impact of diagnosis of hepatitis c virus on quality of life. Hepatology, 30(5), 1299–1301.PubMedCrossRefGoogle Scholar
  4. 4.
    Ketelaars, C. A., Schlösser, M. A., Mostert, R., Huyer, A.-S. H., Halfens, R. J., & Wouters, E. F. (1996). Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 51, 39–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Sprangers, M. A. G., de Regt, E. B., Andries, F., van Agt, H. M., Bijl, R. V., de Boer, J. B., et al. (2000). Which chronic conditions are associated with better or poorer quality of life? Journal of Clinical Epidemiology, 53(9), 895–907.PubMedCrossRefGoogle Scholar
  6. 6.
    Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z. (2002). Impact of diabetes screening on quality of life. Diabetes Care, 25(6), 1022–1102.PubMedCrossRefGoogle Scholar
  7. 7.
    Biondi, B., Palmieri, E. A., Fazio, S., Cosco, C., Nocera, M., Sacca, L., et al. (2000). Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 4701–4705.PubMedGoogle Scholar
  8. 8.
    Helfand, M., & Redfern, C. C. (1998). Clinical guideline, part 2. Screening for thyroid disease: an update. Annals of Internal Medicine, 129, 144–158.PubMedCrossRefGoogle Scholar
  9. 9.
    Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., et al. (1996). Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine, 11, 744–749.PubMedCrossRefGoogle Scholar
  10. 10.
    Adriaanse, M. C., & Snoek, F. J. (2006). The psychological impact of screening for type 2 diabetes. Diabetes/Metabolism Research and Reviews, 22, 20–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Adriaanse, M. C., Dekker, J. M., Spijkerman, A. M. W., Twisk, J. W. R., Nijpels, G., van der Ploeg, H. M., et al. (2004). Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabetic Medicine, 21, 1075–1081.PubMedCrossRefGoogle Scholar
  12. 12.
    Adriaanse, M. C., Snoek, F. J., Decker, J. M., et al. (2003). Perceived risk for type 2 diabetes in participants in a stepwise population screening programme. Diabetic Medicine, 20, 210–215.PubMedCrossRefGoogle Scholar
  13. 13.
    Jackson, D. M., Wills, R., Davies, J., Meadows, K., Singh, B. M., & Wise, P. H. (1991). Public awareness of the symptoms of diabetes mellitus. Diabetic Medicine, 8, 971–972.PubMedCrossRefGoogle Scholar
  14. 14.
    Farmer, A. J., Levy, J. C., & Turner, R. C. (1999). Knowledge of risk of developing diabetes mellitus among siblings of type 2 patients. Diabetic Medicine, 16, 233–237.PubMedCrossRefGoogle Scholar
  15. 15.
    Adriaanse, M. C., Dekker, J. M., Spikerman, A. M. W., Twisk, J. W. R., Nijpels, G., van der Ploeg, H. M., et al. (2004). Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabetic Medicine, 21(10), 1075–1081.PubMedCrossRefGoogle Scholar
  16. 16.
    The Diabetes Prevention Program Research Group. (1999). The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 22, 623–634.PubMedCentralCrossRefGoogle Scholar
  17. 17.
    The Diabetes Prevention Program Research Group. (2002). The Diabetes Prevention Program: recruitment methods and results. Controlled Clinical Trials, 23, 157–171.CrossRefGoogle Scholar
  18. 18.
    The Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393–403.CrossRefGoogle Scholar
  19. 19.
    The Diabetes Prevention Program Research Group. (2000). The Diabetes Prevention Program: Baseline characteristics of the randomized cohort. Diabetes Care, 23, 1619–1629.PubMedCentralCrossRefGoogle Scholar
  20. 20.
    The Diabetes Prevention Program (DPP) Research Group. (2002). The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care, 25, 623–634.CrossRefGoogle Scholar
  21. 21.
    McHorney, C. A., Ware, J. E., & Raczek, A. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.PubMedCrossRefGoogle Scholar
  22. 22.
    Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13, 873–884.PubMedCrossRefGoogle Scholar
  23. 23.
    Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for the two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14(6), 1523–1532.PubMedCrossRefGoogle Scholar
  24. 24.
    Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183–1197.Google Scholar
  25. 25.
    Fine, J. T., Colditz, G. A., Coakley, E. H., Moseley, G., Manson, J. E., Willett, W. C., et al. (1999). A prospective study of weight change and health-related quality of life in women. The Journal of the American Medical Association, 282, 2136–2142.CrossRefGoogle Scholar
  26. 26.
    Kazis, L. E., Miller, D. R., Clark, J., Skinner, K., Lee, A., Rogers, W., et al. (1998). Health-related quality of life in patients served by the Department of Veterans Affairs: Results From the Veterans Health Study. Annals of Internal Medicine, 158(6), 626–632.CrossRefGoogle Scholar
  27. 27.
    Kriska, A.M., Caspersen, C.J. (1997). Introduction to the collection of physical activity questionnaires in a collection of physical activity questionnaires for health-related research. In: Kriska, A.M., Caspersen, C.J. (Eds.), Centers for Disease Control and Prevention. Medicine and Science in Sports and Exercise, 29(Supp), S5–S9.Google Scholar
  28. 28.
    Curran, P. J., Obeidat, K., & Losardo, D. (2010). Twelve frequently asked questions about growth curve modeling. Journal of Cognition and Development, 11(2), 121–136.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Verbeke, G., & Molenberghs, G. (2009). Linear mixed models for longitudinal data. New York: Springer.Google Scholar
  30. 30.
    Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395–404.PubMedCrossRefGoogle Scholar
  31. 31.
    Simon, G. E., Revicki, D. A., Grothaus, L., & Vonkorff, M. (1998). SF-36 summary scores: Are physical and mental health truly distinct? Medical Care, 36(4), 567–572.PubMedCrossRefGoogle Scholar
  32. 32.
    Tuna, H. D., Edeer, A. O., Malkoc, M., & Aksakoglu, G. (2009). Effects of age and physical activity level on functional fitness in older adults. European Review of Aging and Physical Activity, 6(2), 99–106.CrossRefGoogle Scholar
  33. 33.
    Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user’s manual. Boston: The Health Institute, New England Medical Center.Google Scholar
  34. 34.
    Hopman, W. M., Berger, C., Joseph, L., Towheed, T., VandenKerkhof, E., Anastassiades, T., et al. (2006). The natural progression of health related quality of life: Results of a five-year prospective study of the SF-36 scores in a normative population. Quality of Life Research, 15, 527–536.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • D. Marrero
    • 1
    • 2
    Email author
  • Q. Pan
    • 2
  • E. Barrett-Connor
    • 3
  • M. de Groot
    • 1
  • P. Zhang
    • 4
  • C. Percy
    • 5
  • H. Florez
    • 6
  • R. Ackermann
    • 7
  • M. Montez
    • 8
  • R. R. Rubin
    • 9
  • the DPPOS Research Group
  1. 1.Indiana University School of MedicineIndianapolisUSA
  2. 2.DPP Coordinating Center, The Biostatistics CenterGeorge Washington UniversityRockvilleUSA
  3. 3.Department of Family MedicineUniversity of CaliforniaSan DiegoUSA
  4. 4.Centers for Disease Control and PreventionAtlantaUSA
  5. 5.Northern Navajo Medical CenterShiprockUSA
  6. 6.University of Miami Miller School of MedicineMiami VAHS GRECCUSA
  7. 7.Department of MedicineNorthwestern UniversityChicagoUSA
  8. 8.University of Texas Health Science CenterSan AntonioUSA
  9. 9.Departments of Medicine and PediatricsThe Johns Hopkins School of MedicineBaltimoreUSA

Personalised recommendations